• Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF; Note=Type 1: EWSR1 exon 8 fused to ATF1 exon 4 (PubMed=12072203; PubMed=28745431).
  

PubMed=12072203; DOI=10.1016/S0165-4608(01)00641-0
Moritake H., Sugimoto T., Asada Y., Yoshida M.A., Maehara Y., Epstein A.L., Kuroda H.
Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogene.
Cancer Genet. Cytogenet. 135:48-56(2002)

PubMed=28745431; DOI=10.1002/cam4.1130; PMCID=PMC5603837
Nakai T., Imura Y., Tamiya H., Yamada S., Nakai S., Yasuda N., Kaneko K., Outani H., Takenaka S., Hamada K., Myoui A., Araki N., Ueda T., Itoh K., Yoshikawa H., Naka N.
Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma.
Cancer Med. 6:2121-2130(2017)

CLPUB00599
Sugimoto T., Kuroda H., Kuwahara Y., Katsumi Y., Misawa A., Moritake H., Hosoi H.
Cellular and molecular characteristics of established childhood soft-tissue sarcoma cell lines.
J. Cancer Res. Therap. Oncol. 7:202.1-202.12(2019)

PubMed=36959380; DOI=10.1038/s41416-023-02222-0; PMCID=PMC10147623
Rasmussen S.V., Wozniak A., Lathara M., Goldenberg J.M., Samudio B.M., Bickford L.R., Nagamori K., Wright H., Woods A.D., Chauhan S., Lee C.-J., Rudzinski E.R., Swift M.K., Kondo T., Fisher D.E., Imyanitov E.N., Machado I., Llombart-Bosch A., Andrulis I.L., Gokgoz N., Wunder J.S., Moritake H., Nakamura T., Srinivasa G., Thway K., Jones R.L., Huang P.H., Berlow N.E., Schoffski P., Keller C.
Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.
Br. J. Cancer 128:1941-1954(2023)